Changes in CEA expression patterns between inital diagnosis and disease progression may reflect oligoclonality of lung cancer cells with distinct chemoresistant and metastatic properties conferred by EGFR-TKI treatment. This evidence concerns the gene CEACAM5 and lung carcinoma.